PRV-3279-2a Trial in Systemic Lupus

NCT05087628 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Termination for Strategic Reasons

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: PRV-3279
OTHER: Placebo

Sponsor

Provention Bio, a Sanofi Company